NCATS In Vitro and In Vivo Toxicology Studies
IDIQ
Overview
Ceiling
$39,804,016
Primary Sponsoring Agency
Who Can Use
One Agency
Primary NAICS
Primary Set Aside
None
Extent Competed
Full And Open Competition
Related Opportunity
NCATS In Vitro and In Vivo Toxicology Studies awarded by National Institute on Drug Abuse (NIDA) in April 2017 accepts orders through April 2024.
The IDIQ has a reported ceiling of $39,804,016, and as of today, $30,902,952 has been obligated through the vehicle
with a total reported backlog of $4,638,544.
The IDIQ was awarded
full & open and has a primary NAICS code of 541712.
Status
Period of Performance
4/21/17
Start Date
4/20/24
Ordering Period End Date
Task Order Obligations and Backlog
$30.9M
Total Obligated
$30.9M
Current Award
$35.5M
Potential Award
$0.0
Funded Backlog
$4.6M
Total Backlog
Vehicle Award Share
Contractors with greatest percentage of obligations for NCATS In Vitro and In Vivo Toxicology Studies
Vehicle Award Share
Federal Award Analysis
NCATS In Vitro and In Vivo Toxicology Studies contract spending
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Awardees
NCATS In Vitro and In Vivo Toxicology Studies awardees
Contract Awards
NCATS In Vitro and In Vivo Toxicology Studies task orders
Subcontract Awards